• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Metal Complexes for Therapeutic Applications.用于治疗应用的金属配合物。
Trends Chem. 2021 Jul;3(7):523-534. doi: 10.1016/j.trechm.2021.03.006. Epub 2021 Apr 14.
2
Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine.无机化学与生物学的结合:金属配合物在医学中的被低估的潜力。
Chembiochem. 2020 Nov 2;21(21):3044-3046. doi: 10.1002/cbic.202000397. Epub 2020 Sep 8.
3
Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.药用优势查尔酮基金属配合物在生物医学应用中的研究进展。
Eur J Med Chem. 2019 Jul 15;174:142-158. doi: 10.1016/j.ejmech.2019.04.032. Epub 2019 Apr 16.
4
Pyridine coordination chemistry for molecular assemblies on surfaces.表面分子组装的吡啶配位化学。
Acc Chem Res. 2014 Dec 16;47(12):3407-16. doi: 10.1021/ar500112b. Epub 2014 Oct 28.
5
Group 9 organometallic compounds for therapeutic and bioanalytical applications.用于治疗和生物分析应用的 9 组有机金属化合物。
Acc Chem Res. 2014 Dec 16;47(12):3614-31. doi: 10.1021/ar500310z. Epub 2014 Nov 4.
6
Novel metals and metal complexes as platforms for cancer therapy.新型金属和金属配合物作为癌症治疗的平台。
Curr Pharm Des. 2010 Jun;16(16):1813-25. doi: 10.2174/138161210791209009.
7
Antioxidant conjugated metal complexes and their medicinal applications.抗氧化剂共轭金属配合物及其医学应用。
Vitam Horm. 2023;121:319-353. doi: 10.1016/bs.vh.2022.10.003. Epub 2023 Jan 13.
8
Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7.抗癌过渡金属茂和金属配合物:第 4 族到第 7 族元素
Molecules. 2024 Feb 11;29(4):824. doi: 10.3390/molecules29040824.
9
Bioactive luminescent transition-metal complexes for biomedical applications.用于生物医学应用的生物活性发光过渡金属配合物。
Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7666-82. doi: 10.1002/anie.201208414. Epub 2013 Jun 13.
10
Targeting proteins with metal complexes.用金属配合物靶向蛋白质。
Chem Commun (Camb). 2009 Mar 7(9):1001-10. doi: 10.1039/b813568a. Epub 2009 Jan 12.

引用本文的文献

1
Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications.用于医学应用的金属糖缀合物开发的最新进展
Molecules. 2025 Aug 29;30(17):3537. doi: 10.3390/molecules30173537.
2
Current developments of metal- and metalloid-based quinoline compounds as leishmanicidal agents.基于金属和类金属的喹啉化合物作为杀利什曼原虫剂的当前进展。
Front Chem. 2025 May 30;13:1586044. doi: 10.3389/fchem.2025.1586044. eCollection 2025.
3
Iron(III) Complexes with Substituted Salicylaldehydes: Synthesis, Interaction with DNA and Serum Albumins, and Antioxidant Activity.铁(III)与取代水杨醛的配合物:合成、与DNA和血清白蛋白的相互作用以及抗氧化活性
Molecules. 2025 May 29;30(11):2383. doi: 10.3390/molecules30112383.
4
Structural and biomedical investigations of novel ruthenium schiff base complexes.新型钌席夫碱配合物的结构与生物医学研究
Sci Rep. 2025 May 27;15(1):18546. doi: 10.1038/s41598-025-03147-9.
5
Gold(I) -Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents.金(I)-杂环卡宾配合物作为诱导铁死亡的抗癌剂
ACS Med Chem Lett. 2025 Apr 24;16(5):856-864. doi: 10.1021/acsmedchemlett.5c00096. eCollection 2025 May 8.
6
Gli pathway-targeted Co(iii) Schiff base complexes inhibit migration of basal cell carcinoma cells.Gli信号通路靶向的钴(III)席夫碱配合物抑制基底细胞癌细胞的迁移。
RSC Adv. 2025 Mar 19;15(11):8572-8579. doi: 10.1039/d5ra00326a. eCollection 2025 Mar 17.
7
Quinoline conjugates for enhanced antimalarial activity: a review on synthesis by molecular hybridization and structure-activity relationship (SAR) investigation.用于增强抗疟活性的喹啉缀合物:分子杂交合成及构效关系(SAR)研究综述
Am J Transl Res. 2025 Feb 15;17(2):1335-1375. doi: 10.62347/TTHX6526. eCollection 2025.
8
Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming.用于巨噬细胞重编程的工程化形状可调铜配位纳米颗粒
Nano Lett. 2025 Feb 19;25(7):2831-2840. doi: 10.1021/acs.nanolett.4c05999. Epub 2025 Feb 6.
9
2,2'- Bipyridine Derivatives Exert Anticancer Effects by Inducing Apoptosis in Hepatocellular Carcinoma (HepG2) Cells.2,2'-联吡啶衍生物通过诱导肝癌(HepG2)细胞凋亡发挥抗癌作用。
J Hepatocell Carcinoma. 2024 Nov 9;11:2181-2198. doi: 10.2147/JHC.S479463. eCollection 2024.
10
Metal ions in biomedically relevant macromolecular structures.生物医学相关大分子结构中的金属离子。
Front Chem. 2024 Aug 23;12:1426211. doi: 10.3389/fchem.2024.1426211. eCollection 2024.

本文引用的文献

1
Organometallic compounds in drug discovery: Past, present and future.药物发现中的金属有机化合物:过去、现在和未来。
Drug Discov Today Technol. 2020 Dec;37:117-124. doi: 10.1016/j.ddtec.2019.06.001. Epub 2019 Jun 27.
2
Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.将药物化学扩展到三维空间:金属片段作为基于片段药物发现的三维支架
Chem Sci. 2019 Dec 12;11(5):1216-1225. doi: 10.1039/c9sc05586j.
3
Metallodrugs are unique: opportunities and challenges of discovery and development.金属药物独具特色:发现与开发的机遇与挑战
Chem Sci. 2020 Nov 12;11(48):12888-12917. doi: 10.1039/d0sc04082g.
4
A Dinuclear Persulfide-Bridged Ruthenium Compound is a Hypoxia-Selective Hydrogen Sulfide (H S) Donor.双核过硫化物桥联钌配合物是一种缺氧选择性硫化氢(H₂S)供体。
Angew Chem Int Ed Engl. 2021 Jan 18;60(3):1588-1592. doi: 10.1002/anie.202012620. Epub 2020 Nov 16.
5
Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine.无机化学与生物学的结合:金属配合物在医学中的被低估的潜力。
Chembiochem. 2020 Nov 2;21(21):3044-3046. doi: 10.1002/cbic.202000397. Epub 2020 Sep 8.
6
Endoplasmic reticulum stress: an arising target for metal-based anticancer agents.内质网应激:金属类抗肿瘤药物的新兴作用靶点。
Chem Soc Rev. 2020 Nov 21;49(22):8113-8136. doi: 10.1039/d0cs00259c. Epub 2020 Jun 29.
7
Evaluation of 3-Dimensionality in Approved and Experimental Drug Space.已批准药物和实验性药物空间中的三维性评估
ACS Med Chem Lett. 2020 May 18;11(6):1292-1298. doi: 10.1021/acsmedchemlett.0c00121. eCollection 2020 Jun 11.
8
Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes.探讨卵巢癌细胞对铼抗癌配合物的耐药性。
Angew Chem Int Ed Engl. 2020 Aug 3;59(32):13391-13400. doi: 10.1002/anie.202004883. Epub 2020 May 27.
9
Redox Stability Controls the Cellular Uptake and Activity of Ruthenium-Based Inhibitors of the Mitochondrial Calcium Uniporter (MCU).氧化还原稳定性控制基于钌的线粒体钙单向转运体(MCU)抑制剂的细胞摄取和活性。
Angew Chem Int Ed Engl. 2020 Apr 16;59(16):6482-6491. doi: 10.1002/anie.202000247. Epub 2020 Feb 28.
10
A Multi-action and Multi-target Ru -Pt Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.一种结合癌症激活化疗和光动力疗法以克服耐药性癌症的多作用和多靶点钌-铂共轭物
Angew Chem Int Ed Engl. 2020 Apr 27;59(18):7069-7075. doi: 10.1002/anie.201916400. Epub 2020 Mar 11.

用于治疗应用的金属配合物。

Metal Complexes for Therapeutic Applications.

作者信息

Karges Johannes, Stokes Ryjul W, Cohen Seth M

机构信息

Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.

出版信息

Trends Chem. 2021 Jul;3(7):523-534. doi: 10.1016/j.trechm.2021.03.006. Epub 2021 Apr 14.

DOI:10.1016/j.trechm.2021.03.006
PMID:35966501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9374106/
Abstract

Metal complexes have been widely used for applications in the chemical and physical sciences due to their unique electronic and stereochemical properties. For decades the use of metal complexes for medicinal applications has been postulated and demonstrated. The distinct characteristics of metal complexes, including their molecular geometries (that are not readily accessed by organic molecules), as well as their ligand exchange, redox, catalytic, and photophysical reactions, give these compounds the potential to interact and react with biomolecules in unique ways and by distinct mechanisms of action. Herein, the potential of metal complexes to act as components bioactive therapeutic compounds is discussed.

摘要

金属配合物因其独特的电子和立体化学性质,已在化学和物理科学领域得到广泛应用。几十年来,人们一直在推测并证明金属配合物在医学上的应用。金属配合物的独特特性,包括其分子几何结构(这是有机分子难以实现的)以及它们的配体交换、氧化还原、催化和光物理反应,使这些化合物有可能以独特的方式和不同的作用机制与生物分子相互作用并发生反应。本文讨论了金属配合物作为生物活性治疗化合物成分的潜力。